Merck 3Q Profit Jumps 62 Pct
The Whitehouse Station, N.J.-based maker of osteoporosis treatment Fosamax and Singulair for asthma and allergies reported net income of $1.53 billion, or 70 cents per share, for the three months ended Sept. 30 up from $940.6 million, or 43 cents per share, a year earlier.....